DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Sophie Yu Martin Quin Pollard"


2 mentions found


☆ In China, no easy way to get Pfizer's COVID drug Paxlovid
  + stars: | 2023-01-16 | by ( Sophie Yu Martin Quin Pollard | Sophie Yu | Martin Quin Pollard | ) www.reuters.com   time to read: +6 min
He heard at that time that Pfizer's (PFE.N) anti-viral drug Paxlovid was an effective treatment, but patients could only get it prescribed if they were admitted to hospital, and only if the drug was in stock. Li's experience, local media reports and online posts bear testimony to the difficulties faced obtaining Paxlovid in China through official channels. "Pfizer is actively collaborating with Chinese authorities and all stakeholders to secure an adequate supply of Paxlovid in China. We remain committed to fulfilling the COVID-19 treatment needs of Chinese patients and partnering with the Chinese government," the company said in a statement. PAXLOVID GIFTSeveral other people described to Reuters how they turned to the grey market to purchase Paxlovid.
☆ 'Daylight is here': China travel searches surge as public cheers COVID easing
  + stars: | 2022-12-07 | by ( Sophie Yu Martin Quin Pollard | Sophie Yu | Martin Quin Pollard | ) www.reuters.com   time to read: +4 min
REUTERS/Thomas PeterBEIJING, Dec 7 (Reuters) - Searches on Chinese travel sites surged and social media platforms were flooded with delight and relief on Wednesday as the public cheered the biggest loosening of some of the world's strictest COVID policies. CAUTIOUS OPTIMISM, EXHAUSTIONThe news was also welcomed by foreign business groups, many of which had become increasingly outspoken about the damage the zero-COVID policy was having on China's economy and the operations of their companies. "Timely implementation will help stabilise China’s economy and get life back to normal," the European Chamber of Commerce in China said of the 10 measures announced on Wednesday. It also urged China to roll out mRNA vaccines for domestic use as part of a vaccination drive with the elderly a priority. Reporting by Sophie Yu and Martin Pollard, Writing by Brenda Goh; Editing by Robert BirselOur Standards: The Thomson Reuters Trust Principles.
0 next >>
Total: 2